Gastrointestinal Cancer
From the Journals
Study shows childhood IBD increased cancer risk in adulthood
Childhood inflammatory bowel disease was associated with significant increases in the risk of cancer in later life.
From the Journals
Consider adding chemotherapy after GI surgery
Average survival rates at 3 years after surgery were 40 months for those who received adjuvant chemotherapy vs. 34 months for those who did not....
News
FDA approves nivolumab for HCC patients
Approval of nivolumab for HCC was based on tumor response rate and durability of response from the phase 1/2 Checkmate 040 trial.
News
FDA approves biosimilar to bevacizumab
Bevacizumab-awwb is approved for the treatment of adults with certain colorectal, lung, brain, kidney, and cervical cancers.
Conference Coverage
Minimally invasive esophagectomy may mean less major morbidity
COLORADO SPRINGS – Shorter LOS also seen in ACS-NSQIP analysis
From the Editor
An ASCO 2017 recap: significant advances continue
Case Reports
Management of high-grade pleomorphic sarcoma with colon metastasis
From the Journals
Reduced starting dose of sorafenib for HCC appears safe
The initiation of sorafenib at a reduced dosage may be a safe and reasonable strategy for some patients with hepatocellular carcinoma.
Feature
Is pain or dependency driving elevated opioid use among long-term cancer survivors?
Rates of opioid prescribing were about 1.2 times higher overall among cancer survivors up to 10 years after diagnosis, compared with matched...
From the Journals
No overall survival benefit from early SIRT for liver metastases from colorectal cancer
“Early use of SIRT in combination with first-line oxaliplatin-based chemotherapy cannot be recommended in unselected patients with metastatic...
Feature
Award for best hospital goes to … the Mayo Clinic
The U.S. News Best Hospitals Honor Roll for 2017-2018 includes the usual suspects, with the University of Michigan making a big move up the list...